In 20–55% of hospitalized patients with COVID-19, elevated D-dimer levels of more than twice the normal value, a slightly prolonged prothrombin time (1–3 s above normal), and mild thrombocytopenia have been observed (42). This evidence concerns the gene F2 and COVID-19.